HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
View/ Open
Date
2015Author
Budambula, Valentine
Musumba, Francis O.
Webale, Mark K.
Kahiga, Titus M.
Ongecha‑Owuor, Francisca
. Kiarie, James N.
Sowayi, George A.
Ahmed, , Aabid A.
Ouma, Collins
Were, Tom
Metadata
Show full item recordAbstract
Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations and their association with viral load and CD4+ T cell counts in HIV-1 infected IDUs (ART-naive, n = 32; and -experienced, n = 47) and non-drug users (ART-naive, n = 21; and -experienced, n = 32) naive for PI treatment from coastal Kenya.